GenoLogics to Provide Platform and Data Management System to SGUL
News Feb 21, 2006
GenoLogics Life Sciences Software Inc. has announced that the St. George’s, University of London (SGUL) Medical Biomics Centre has selected GenoLogics to provide their lab and scientific data management system.
The SGUL Medical Biomics Centre is a centre for the integration of genomics, transcriptomics, proteomics and metabolomics technologies applied to medical and biomedical research.
According to SGUL’s Dr. Gary Coulton, Associate Dean for Enterprise and Innovation, "We needed to address the data deluge coming from our diverse research activities and to provide a secure environment for data management."
"Our major need was a LIMS and data management systemcapable of integrating multiple technologies and also handling data from many research teams (currently over 50), including our academic, clinical and commercial partners."
"It needed to be flexible and user friendly but designed to be able to satisfy both academic and industrial users."
"We felt our ideal system had to provide data security but also have provision for web-access by external collaborators. It had to be scalable and have the potential for future development."
"We looked at a number of systems all of which had strengths but we felt that ProteusLIMS from GenoLogics best met our criteria," says Dr. Coulton.
The system is designed to combine the capability of managing the complex data arising from conventional proteomic studies with the flexibility to accommodate new approaches developed within the Medical Biomics Centre.
"The SGUL team was also impressed by GenoLogics’ commitment to developing a system that will accommodate the wide variety of data arising from integration of the different Biomic technologies," says Dr.Coulton. Michael Ball, CEO of GenoLogics.
"We also rapidly developed a strong collaborative relationship with GenoLogics that is very important to us and is the basis for this new partnership."
"We very much value our customers’ input and partnering with customers has helped us be the leader of purposed systems biology lab and data management solutions for research organizations and companies involved in biomarker and drug discovery."
"Customers are clear they need a solution that will enable data sharing across proteomics, genomics and other science domains and GenoLogics’ open integrating platform and data management solution is designed perfectly for that purpose."
In treating inflammatory bowel disease (IBD), physicians can have a hard time telling which newly diagnosed patients have a high risk of severe inflammation or what therapies will be most effective. Now researchers report finding an epigenetic signature in patient cells that appears to predict inflammation risk in a serious type of IBD called Crohn’s disease.